Get started
Live feed
PRReleasevia Quantisnow
Creative Medical Technology Holdings Inc. logo

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for CELZ

Across the 9 sessions after earlier CELZ headlines, the stock closed higher 4 times and lower 5 times, with a median move of 9.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

CELZ close-to-close change in the session after earlier headlines
SessionEarlier headlineCELZSPY
Apr 28, 2026Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies-2.2%-0.5%
Feb 10, 2026Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline+1.6%-0.3%
Jan 13, 2026Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain-11.2%-0.2%
Jan 6, 2026Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative+9.3%+0.6%
Dec 17, 2025Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point+1.2%-1.1%
Dec 2, 2025Creative Medical Technology Holdings Announces World Health Organization Approval of "olastrocel" as INN for Lead Allogeneic Cell Therapy CELZ-201-11.8%+0.2%
Quantisnow market dataNASDAQ
Creative Medical Technology Holdings Inc. logo
CELZ
Creative Medical Technology Holdings Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for CELZ

Follow CELZ and get a push notification the moment its next story breaks.

Full CELZ profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELZ (Creative Medical Technology Holdings Inc.) and more on Quantisnow.